TOMI Environmental Solutions, Inc. TOMZ

Healthcare SIC 2860 - Industrial Organic Chemicals NAICS Manufacturing › Chemical Manufacturing › Basic Chemical Manufacturing › Other Basic Organic Chemical Manufacturing derived Nasdaq

TOMI Environmental Solutions, Inc. ("TOMI," "we," "our," or the "Company") is a global provider of disinfection and decontamination solutions, offering environmentally friendly products and services for indoor air and surface treatment. Our flagship product line, SteraMist uses our patented Binary Ionization Technology ("BIT") to deliver a low-concentration (7.8%) hydrogen peroxide-based fog or mist that effectively treats all indoor environments and surface areas.

Developed under a grant from the United States Defense Advanced Research Projects Agency ("DARPA"), SteraMist generates ionized Hydrogen Peroxide ("iHP") through a high-voltage atmospheric cold plasma arc, converting hydrogen peroxide solution into submicron hydroxyl radical particles. This process achieves a 6-log (99.9999%) or greater kill rate against a broad spectrum of pathogens, leaving only oxygen and humidity as by-products. We maintain U.S. Environmental Protection Agency ("EPA") registration for our BIT solution, along with applicable regulatory approvals in all 50 states, Washington D.C., Canada, and approximately 40 other countries.

Last close 1.46 2026-10-23
Market cap $11.9M 2026-06-30 share count
52-week range 1.21 - 3.32

Valuation FY2025 figures against the last close

P/S2.1x
P/E—
P/FCF—
EV/EBITDA—
Dividend yield—
Diluted EPS-0.19

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $5.6M$7.7M$7.4M$8.3M$7.8M$25.0M$6.3M$5.6M$5.0M$6.3M
Cost of revenue $2.6M$4.2M$3.1M$3.3M$3.2M$10.0M$2.4M$2.5M$1.9M$2.6M
Gross profit $3.1M$3.6M$4.3M$5.1M$4.6M$15.0M$3.9M$3.1M$3.1M$3.7M
R&D $289.9K$290.7K$491.8K$352.2K$572.7K$455.0K$340.6K$916.0K$454.1K$184.3K
SG&A $4.5M$5.1M$4.6M———————
Total operating expenses $6.9M$7.7M$7.6M$7.9M$9.5M$10.5M$6.0M$6.2M$6.5M$7.1M
Operating income -$3.9M-$4.1M-$3.3M-$2.9M-$4.9M$4.5M-$2.1M-$3.1M-$3.4M-$3.4M
Interest expense ——$63.3K$0$1.0K$43.5K$200.0K$221.9K$191.3K$0
Pre-tax income -$3.7M-$4.5M-$3.4M-$2.9M-$4.5M$4.5M-$2.3M-$3.2M-$3.6M-$3.2M
Income tax $0$0$0$0$74.1K$77.0K$0$0$0$0
Net income -$3.7M-$4.5M-$3.4M-$2.9M-$4.4M$4.4M-$2.3M-$3.2M-$3.6M-$3.2M
EPS, basic -0.19-0.22-0.17-0.15-0.250.27-0.15———
EPS, diluted -0.19-0.22-0.17-0.15-0.250.23-0.15-0.03-0.03-0.03
Shares, diluted (wtd. avg.) 20.1M20.0M19.8M19.7M17.5M18.8M15.6M———

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $87.8K$88.0K$2.3M$3.9M$5.3M$5.2M$897.2K$2.0M$4.6M$948.3K
Receivables $689.2K$1.9M$2.4M$2.8M$2.0M$3.7M$1.5M$2.1M$1.8M$1.5M
Inventory $2.9M$3.6M$4.6M$4.5M$4.7M$3.8M$2.3M$2.7M$3.5M$4.0M
Total current assets $4.2M$6.5M$10.0M$12.1M$12.9M$13.7M$5.0M$7.2M$10.2M$6.8M
Property, plant and equipment $614.3K$875.4K$1.0M$1.3M$1.5M$1.3M$1.4M$1.6M$712.8K$611.8K
Other intangibles $1.4M$1.3M$1.1M$1.0M$956.3K$722.9K$939.0K$1.2M$1.5M$1.9M
Total assets $7.0M$9.7M$13.4M$15.5M$16.3M$16.8M$8.2M$10.1M$12.4M$9.3M
Accounts payable $1.5M$1.9M$1.3M$1.8M$1.1M$1.5M$713.2K$1.1M$751.7K$735.9K
Total current liabilities $3.2M$2.7M$2.1M$3.3M$1.8M$2.2M$6.3M$1.7M$1.1M$1.1M
Long-term debt $3.1M—————$5.0M$5.0M$5.9M—
Total liabilities $6.4M$5.6M$5.0M$4.1M$2.7M$3.6M$7.3M$7.1M$7.0M$1.1M
Retained earnings -$58.1M-$54.3M-$49.8M-$46.4M-$43.5M-$39.1M-$43.5M-$41.2M-$38.0M-$34.3M
Total equity $588.5K$4.1M$8.4M$11.4M$13.6M$13.2M$889.5K$3.0M$5.4M$8.3M

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow -$1.2M-$1.4M-$3.6M-$1.2M-$3.8M$4.6M-$814.5K-$1.8M-$2.4M-$4.5M
Depreciation and amortisation $241.5K$270.2K$345.6K$314.7K$299.7K$342.5K$345.7K$265.2K$237.6K$216.9K
Stock-based compensation $147.0K$144.3K$163.3K$653.8K—$3.1M$114.2K$77.2K$649.3K$614.7K
Capital expenditure $5.2K$107.9K$98.1K$200.9K—$289.3K$145.6K$628.1K$14.8K$474.9K
Investing cash flow -$135.6K-$261.5K-$216.7K-$241.4K-$639.4K-$400.7K-$293.3K-$628.1K-$14.8K-$462.9K
Financing cash flow $755.1K$27.5K$2.3M$25.0K$4.6M$124.2K$0-$150.0K$6.0M$0

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001654954-26-003091.

Plot the figures US dollars

  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. -10M 0 10M 20M 30M Revenue, FY2016: 6.3M Gross profit, FY2016: 3.7M Net income, FY2016: -3.2M Revenue, FY2017: 5M Gross profit, FY2017: 3.1M Net income, FY2017: -3.6M Revenue, FY2018: 5.6M Gross profit, FY2018: 3.1M Net income, FY2018: -3.2M Revenue, FY2019: 6.3M Gross profit, FY2019: 3.9M Net income, FY2019: -2.3M Revenue, FY2020: 25M Gross profit, FY2020: 15M Net income, FY2020: 4.4M Revenue, FY2021: 7.8M Gross profit, FY2021: 4.6M Net income, FY2021: -4.4M Revenue, FY2022: 8.3M Gross profit, FY2022: 5.1M Net income, FY2022: -2.9M Revenue, FY2023: 7.4M Gross profit, FY2023: 4.3M Net income, FY2023: -3.4M Revenue, FY2024: 7.7M Gross profit, FY2024: 3.6M Net income, FY2024: -4.5M Revenue, FY2025: 5.6M Gross profit, FY2025: 3.1M Net income, FY2025: -3.7M FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue $6.3M $5.0M $5.6M $6.3M $25.0M $7.8M $8.3M $7.4M $7.7M $5.6M
Gross profit $3.7M $3.1M $3.1M $3.9M $15.0M $4.6M $5.1M $4.3M $3.6M $3.1M
Net income -$3.2M -$3.6M -$3.2M -$2.3M $4.4M -$4.4M -$2.9M -$3.4M -$4.5M -$3.7M

Recent filings and events

  • Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Results announced Item 2.02
  • Charter or fiscal year changed A change to the company's governing documents, or to when its year ends. Item 5.03
  • Other event Item 8.01
  • Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
  • Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
  • Shareholder vote The results of the annual meeting or a special vote. Item 5.07
  • Delisting notice The exchange has told the company it no longer meets the rules for staying listed - usually price, market cap, or filings that are late. Item 3.01
  • Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
  • Other event Item 8.01
  • Results announced Item 2.02

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 2860

TickerCompanyMarket capP/ERevenue growth
IFF INTERNATIONAL FLAVORS & FRAGRANCES INC $24.02B — -5.2%
LYB LyondellBasell Industries N.V. $21.47B — -9.7%
WLK WESTLAKE CORP $8.25B — -8.0%
NEU NEWMARKET CORP $8.01B 19.6x -2.2%
SXT SENSIENT TECHNOLOGIES CORP $5.65B 42.0x 3.5%
REX REX AMERICAN RESOURCES Corp $1.32B 15.9x 1.2%
GPRE Green Plains Inc. $979.9M — 16.0%
WLKP Westlake Chemical Partners LP $745.5M — 2.7%